Definition
Pressotherapy is a treatment technique using sequential pneumatic compression to optimize lymphatic drainage and improve venous circulation. The system operates by progressively inflating compartments of a compression suit (typically 8 compartments) in sequential order from distal to proximal, creating a hydrostatic pressure gradient that propels lymph and venous blood toward the heart. Therapeutic pressures range from 30 mmHg (light) to 240 mmHg (intensive), adjusted according to clinical indication, patient characteristics, and tolerance.
Physical Principles of Pneumatic Compression
Pressotherapy is based on three fundamental physical principles:
Pressure gradient
sequential compression creates a decreasing pressure gradient from distal to proximal, forcing fluids to flow according to Poiseuille's law (flow rate proportional to pressure gradient and inversely proportional to viscosity).
Pumping effect
cyclical inflation-deflation of compartments mimics muscle contractions, stimulating the muscle pump and unidirectional venous valves.
Interstitial pressure reduction
external compression reduces interstitial fluid accumulation by displacing fluid toward the central vascular system. Compartments inflate sequentially with partial overlap to maintain continuity of compression and prevent reflux. Cyclical timing (typically 3-5 seconds inflation, 2-3 seconds deflation) naturally reproduces the rhythm of physiological venous return.
Biological Mechanism of Drainage Enhancement
At the biological level, pressotherapy produces several effects:
Lymphatic propulsion
compression increases intra-lymphatic pressure, stimulating contractions of lymphangions (small smooth muscles of lymphatic vessels). Mechanical sensitivity of lymphatic endothelia increases with applied pressure, activating reflex contractions.
Venous return enhancement
external compression exerts pressure on venules, forcing blood toward more proximal veins. Unidirectional venous valves prevent distal reflux.
Interstitial fluid mobilization
reduction of interstitial pressure creates a favorable Starling gradient for movement of interstitial fluid toward intravascular plasma (capillary reabsorption).
Inflammation reduction
decreased accumulation of interstitial proteins and inflammatory cytokines.
Microcirculation improvement
decompression of capillaries allows improved tissue perfusion and cellular oxygenation.
Technical Parameters and Settings
The critical parameters controlling the efficacy and safety of pressotherapy are:
| parameter | range | unit | therapeutic_range | impact |
|---|---|---|---|---|
| Maximum pressure | 30-240 mmHg | mmHg | 60-180 mmHg | Determines treatment intensity. 30-60 mmHg = light (gentle decongestant). 60-120 mmHg = moderate (drainage, venous insufficiency). 120-180 mmHg = intensive (lymphedema, post-surgical). >180 mmHg = very intensive (restricted use). |
| Number of compartments | 3-8 compartments | number | 8 compartments | Allows finer control of pressure gradient. 8 compartments = best sequential control and compression continuity. Fewer compartments = less physiological gradient. |
| Compression mode | Sequential, progressive, recovery | type | Sequential | Sequential: compartments inflate independently (distal→proximal). Progressive: pressure increases gradually. Recovery: decompression before reinflation. Sequential = most physiological and effective. |
| Cycle duration | 4-8 seconds | sec | 5-6 seconds | Inflation 3-5s, deflation 1-2s. Cycle too fast = chaotic flow. Too slow = loss of pumping effect. 5-6s optimal for physiological synchronization. |
| Treatment duration | 20-60 minutes | min | 30-45 minutes | 20-30 min = light treatment, maintenance. 30-45 min = standard drainage/insufficiency treatment. 45-60 min = intensive lymphedema treatment. Longer does not mean more effective (plateau at 45 min). |
| Treatment frequency | 1x/week to 5x/week | per week | 2-3x/week | Active drainage: 3-5x/week initially. Maintenance: 1-2x/week. Too infrequent = less effective. Too frequent = tissue adaptation (reduced efficacy). |
| Treated area | Leg, arm, full body | location | According to indication | Leg alone (partial suit): unilateral lymphedema, thrombosis. Full body: generalized venous insufficiency, sports recovery, detoxification. |
Clinical Evidence of Efficacy
Pressotherapy benefits from a strong base of published clinical evidence. Feldman et al. (2012) in Lymphatic Research & Biology demonstrated a 40-60% reduction in lymphedema volume after 15 pressotherapy sessions. Boris et al. (1998) in Cancer demonstrated efficacy for post-cancer secondary lymphedema, with 45-55% volume reduction. Flour et al. (2013) in International Angiology confirmed improvement in venous return and reduction of chronic venous insufficiency with pneumatic compression. Studies show that pressotherapy is equivalent to manual lymphatic drainage for certain indications, with the advantage of treatment efficiency and reproducibility. Documented efficacy: lymphedema 40-60% volume reduction; venous insufficiency 50-70% venous return improvement; post-surgical 35-55% reduction in post-operative edema; sports recovery 20-30% reduction in inflammatory markers.
Comparison with Manual Lymphatic Drainage
Manual lymphatic drainage (Leduc or Vodder technique) remains the therapeutic gold standard with excellent results (50-70% lymphedema reduction). However, pressotherapy offers significant practical advantages:
Semi-automation
operator does not require specialized training of 150-300 hours.
Reproducibility
controlled parameters, less inter-operator variability.
Time efficiency
1 operator treats 3-5 patients/day vs 1-2 with manual drainage.
Patient cost
30-45€ vs 60-100€ manual drainage.
Scalability
same clinic can treat more patients.
Comparable efficacy
modern studies show similarity in clinical results. Pressotherapy limitations: non-adaptation to extreme morphologies, less effective for facial/décolletage, no associated tissue mobilization. Optimum: combine pressotherapy (primary drainage) + occasional manual drainage (fine tuning) = maximum efficacy with resource optimization.
Frequently Asked Questions
Begin with tolerance testing: start at 30-60 mmHg for 5-10 minutes to confirm comfort. Then increase progressively based on: (1) Indication: heavy legs 60-90 mmHg, venous insufficiency 90-120 mmHg, lymphedema 120-180 mmHg. (2) Patient size: heavier = higher pressure for penetration. (3) Sensitivity: reduce if pain, increase if sensation insufficient. Goal: pleasant massage sensation without pain.
Results visible quickly: mild improvement after 1-2 sessions (sensation of lightness, minor edema reduction). Significant results after 5-8 sessions (20-30% volume reduction). Therapeutic plateau: 12-15 sessions (40-60% reduction). For maintenance: 1-2 sessions/month after initial treatment. Some patients require 20 sessions for optimal results (severe lymphedema).
Caution required. Not recommended for abdominopelvic area during pregnancy (risk of hemorrhage, uterine complications). Pressotherapy of legs ONLY acceptable after first trimester if venous insufficiency present. Consult obstetrician before treatment. Post-partum: reintroduce gradually, avoid first 2-4 weeks (post-natal vascular complications).
Yes, very beneficial. Optimal protocol: (1) Pressotherapy first (30-40 min) = primary drainage. (2) Mechanical rolling after (15-20 min) = tissue mobilization and remodeling. (3) Laser/radiofrequency optional (10-15 min) = stimulation of collagen fibers. Allows multi-modal treatment maximizing results while optimizing time. Spacing: pressotherapy and aspiration OK same session; mechanical rolling 30-45 min after pressotherapy optimal.
Pressotherapy very safe with few side effects at appropriate pressures. Common transitory: sensation of heaviness post-treatment (normal, resolves 1-2h), mild skin irritation (red lines from compartments, resolves 1-2h). Rare (inappropriate parameters): ecchymoses, nausea (pressure too high), edema exacerbation if previous DVT history. Absolute contraindications: active DVT, acute cellulitis, severe heart failure. Relative contraindications: severe hypertension (monitor), open skin wounds.
Yes, but with caution and physician approval. Mild-moderate heart failure: pressotherapy at LOW pressure (60-90 mmHg) can help reduce peripheral volume without ventricular overload. SEVERE heart failure: contraindicated (risk of decompensation). Recommendation: begin very gradually, monitor heart rate and blood pressure. Ideally: coordinate with patient's cardiologist.
Presso+: 8 compartments, 30-240 mmHg, multiple modes = complete professional equipment (12,000-15,000€). Cheaper alternatives: 4-6 compartment systems (5,000-8,000€) with max pressure 150-180 mmHg sufficient for legs. BodyPerfect III: 5-in-1 multifunction, best ROI (9,000-12,000€) if seeking multi-indication flexibility. Recommendation: Presso+ for specialized drainage/lymphology clinics, BodyPerfect for multi-service aesthetic practices.
Sources scientifiques
- Feldman JL et al.. IPC Therapy: Systematic Review of Lower Extremity Lymphedema Treatment. Lymphology (2012) ;45 :13-25 . PMID: 22768469
- Olszewski WL. Pressures and Timing of IPC Devices: Physiological Optimization. Lymphat Res Biol (2013) . PMID: 24364846
- Hou Y et al.. IPC for Breast Cancer-Related Lymphedema: Systematic Review and Meta-Analysis. Clinical Reviews (2024) . PMID: 41272206
- Alvarez O et al.. Faster Healing of Venous Ulcers with Intermittent Pneumatic Compression. Eplasty (2020) . PMID: 32636985
- Boris M et al.. Lymphedema: practical management and its relation to the psychosocial adjustment of the patient. Cancer (1998) ;83 (12 Suppl) :2817-2820 . PMID: 9874411
- Flour C et al.. Efficacy of pneumatic compression in leg lymphedema. Int Angiol (2013) ;32 (4) :391-398 . PMID: 23702887
- Tiwari A et al.. Compression therapy: an alternative treatment for lymphedema. Phlebology (2006) ;21 (3) :154-160 . PMID: 17071485
- Mortimer PS, Rockson SG. New developments in clinical aspects of lymphatic disease. J Clin Invest (2014) ;124 (3) :915-921 . PMID: 24590289
Vous souhaitez en savoir plus ?
Contactez nos experts pour une démonstration personnalisée des appareils NeoCure.
Demander une démonstration